Document is current
Any future updates will be listed below
-
Authors
Ruisch, I. Hyun
Widomska, Joanna
De Witte, Ward
Mota, Nina R.
Fanelli, Giuseppe
Van Gils, Veerle
Jansen, Willemijn J.
Vos, Stephanie J. B.
Fóthi, Abel
Barta, Csaba
Berkel, Simone
Alam, Kazi A.
Martinez, Aurora
Haavik, Jan
O’Leary, Aet
Slattery, David
Sullivan, Mairéad
Glennon, Jeffrey
Buitelaar, Jan K.
Bralten, Janita
Franke, Barbara
Poelmans, Geert
-
Funding
Funding for this research was provided by:
European Community’s Horizon 2020 Programme (847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME), 847879 (PRIME))
Research Council of Norway (331725)
the Innovative Medicines Initiative 2 Joint Undertaking (101034377 (PRISM2))
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 21 October 2024
First Online: 28 October 2024
Declarations
:
: Not applicable (ethical approval and consent to participate was obtained by each individual study, of which the published results and/or publicly available data were used as input for the current study).
: Not applicable.
: G.P. is director and I.H.R., J.W. and W.D.W. are employees of Drug Target ID, Ltd., but their activities at this company do not constitute competing interests with regard to this paper. J.K.B. has been in the past 3 years a consultant to / member of advisory board of / and/or speaker for Takeda, Roche, Medice, Angelini, Neuraxpharm, and Servier, all unrelated to this manuscript. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. B.F. has received educational speaking fees from Medice GmbH. N.R.M., G.F., V.V.G., W.J.J., S.J.B.V., A.F., C.B., S.B., K.A.A., A.M., J.H., A.O.L., D.S., M.S., J.G. and J.B. do not report any conflicts of interest. In addition, the funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
